Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	The Word Brain 2015 – Free PDF | Print | Web A short guide to fast language learning	Free Abstracts

Autoimmune Disorders

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 68 articles: HTML format Text format

Single Articles

December 2012
1. SCHIRMER L , Rothhammer V, Hemmer B, Korn T, et al
   Enriched CD161high CCR6+ gammadelta T Cells in the Cerebrospinal Fluid of Patients With Multiple Sclerosis.
   Arch Neurol. 2012 Dec 17:1-7. doi: 10.1001/2013.
   PubMed     Text format     Abstract available
   
   
   
2. ALTAY EE , Fisher E, Jones SE, Hara-Cleaver C, et al
   Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.
   Arch Neurol. 2012 Dec 17:1-7. doi: 10.1001/2013.
   PubMed     Text format     Abstract available
   
   
   November 2012
3. GREENBERG BM , Balcer L, Calabresi PA, Cree B, et al
   Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
   Arch Neurol. 2012 Nov 5:1-4. doi: 10.1001/jamaneurol.2013.1017.
   PubMed     Text format     Abstract available
   
   
   
4. DOROTHEE G , de Souza LC, Sarazin M, Aucouturier P, et al
   Plasma Anti-Amyloid-beta Autoantibodies in All Alzheimer Disease Types-Reply.
   Arch Neurol. 2012;69:1525-7.
   PubMed     Text format    
   
   
   
5. TREMOLIZZO L , Conti E, Appollonio I, Ferrarese C, et al
   Plasma Anti-Amyloid-beta Autoantibodies in All Alzheimer Disease Types.
   Arch Neurol. 2012;69:1525-7.
   PubMed     Text format    
   
   
   
6. GAJOFATTO A , Benedetti MD
   Prognostic factors of acute partial transverse myelitis.
   Arch Neurol. 2012;69:1523.
   PubMed     Text format    
   
   
   
7. QIAN P , Lancia S, Alvarez E, Klawiter EC, et al
   Association of neuromyelitis optica with severe and intractable pain.
   Arch Neurol. 2012;69:1482-7.
   PubMed     Text format     Abstract available
   
   
   October 2012
8. MCKEON A , Martinez-Hernandez E, Lancaster E, Matsumoto JY, et al
   Glycine Receptor Autoimmune Spectrum With Stiff-Man Syndrome Phenotype.
   Arch Neurol. 2012 Oct 22:1-9. doi: 10.1001/jamaneurol.2013.
   PubMed     Text format     Abstract available
   
   
   
9. PLEASURE D
   GlyRalpha1, GAD65, Amphiphysin, and Gephyrin Autoantibodies: Leading or Supporting Roles in Stiff-Person Disorders?
   Arch Neurol. 2012 Oct 22:1-2. doi: 10.1001/jamaneurol.2013.
   PubMed     Text format    
   
   
   
10. SAIDHA S , Sotirchos ES, Oh J, Syc SB, et al
    Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
    Arch Neurol. 2012 Oct 1:1-10. doi: 10.1001/archneurol.2013.
    PubMed     Text format     Abstract available
    
    
    
11. GREEN AJ
    Getting Beyond the Ganglion Cell: Morphometric Adjustments for Retinal Optical Coherence Tomography in Multiple Sclerosis.
    Arch Neurol. 2012 Oct 1:1-3. doi: 10.1001/archneurol.2013.
    PubMed     Text format    
    
    
    
12. MARDER E , Gupta P, Ragland M, Stuve O, et al
    Cerebral and cervical venous outflow abnormalities are dynamic.
    Arch Neurol. 2012;69:1380-1.
    PubMed     Text format    
    
    
    September 2012
13. ARELLANO B , Hussain R, Zacharias T, Yoon J, et al
    Human Aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with Neuromyelitis Optica.
    Arch Neurol. 2012;69:1125-31.
    PubMed     Text format     Abstract available
    
    
    
14. MEALY MA , Wingerchuk DM, Greenberg BM, Levy M, et al
    Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
    Arch Neurol. 2012;69:1176-80.
    PubMed     Text format     Abstract available
    
    
    
15. YAFFE K , Falvey C, Hamilton N, Schwartz AV, et al
    Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.
    Arch Neurol. 2012;69:1170-5.
    PubMed     Text format     Abstract available
    
    
    August 2012
16. GOVINDARAJAN R , Salgado E
    Is it too early to predict the failure of natalizumab in NMO?
    Arch Neurol. 2012;69:1085.
    PubMed     Text format    
    
    
    
17. KIM SM , Go MJ, Sung JJ, Park KS, et al
    Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics.
    Arch Neurol. 2012;69:1026-31.
    PubMed     Text format     Abstract available
    
    
    July 2012
18. FENG X , Han D, Kilaru BK, Franek BS, et al
    Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
    Arch Neurol. 2012 Jul 16:1-7. doi: 10.1001/archneurol.2012.
    PubMed     Text format     Abstract available
    
    
    
19. KORTH C
    Identification of Dominant Human Aquaporin 4 T-Cell Epitopes: Observations in Neuromyelitis Optica With Implications for Other Autoimmune DisordershAQP4 T-Cell Epitopes.
    Arch Neurol. 2012 Jul 2:1-2. doi: 10.1001/archneurol.2012.1561.
    PubMed     Text format    
    
    
    
20. RADUE EW , O'Connor P, Polman CH, Hohlfeld R, et al
    Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
    Arch Neurol. 2012 Jul 2:1-11. doi: 10.1001/archneurol.2012.1051.
    PubMed     Text format     Abstract available
    
    
    
21. REEKERS JA
    IDEAL for CCSVI research.
    Arch Neurol. 2012;69:939-40.
    PubMed     Text format    
    
    
    
22. BICHUETTI DB , Oliveira EM, Boulos Fde C, Gabbai AA, et al
    Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
    Arch Neurol. 2012;69:938-9.
    PubMed     Text format    
    
    
    June 2012
23. ROWLAND LP
    Seronegative Myasthenia Gravis: The Importance of Clusters of Acetylcholine ReceptorsSeronegative Myasthenia Gravis.
    Arch Neurol. 2012 Jun 11:1-2. doi: 10.1001/archneurol.2012.
    PubMed     Text format    
    
    
    
24. JACOB S , Viegas S, Leite MI, Webster R, et al
    Presence and Pathogenic Relevance of Antibodies to Clustered Acetylcholine Receptor in Ocular and Generalized Myasthenia GravisClustered AChR Antibodies in Myasthenia Gravis.
    Arch Neurol. 2012 Jun 11:1-8. doi: 10.1001/archneurol.2012.
    PubMed     Text format     Abstract available
    
    
    
25. MARCUS JF , Goodin DS, Harris CA, Josephson SA, et al
    Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
    Arch Neurol. 2012;69:793-4.
    PubMed     Text format    
    
    
    
26. HANWELL HE , Kimball SM
    Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring.
    Arch Neurol. 2012;69:793-4.
    PubMed     Text format    
    
    
    
27. CLARK CN , Saifee TA, Cowley PO, Ginsberg L, et al
    Dural Arteriovenous Fistula of the Medulla Initially Mimicking Guillain-Barre SyndromeDural Arteriovenous Fistula of the Medulla.
    Arch Neurol. 2012;69:786-7.
    PubMed     Text format    
    
    
    
28. BRAUNSCHWEIG D , Van de Water J
    Maternal Autoantibodies in AutismMaternal Autoantibodies in Autism.
    Arch Neurol. 2012;69:693-9.
    PubMed     Text format     Abstract available
    
    
    
29. MELZER N , Harder A, Gross CC, Wolfer J, et al
    CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid beta-related angiitis.
    Arch Neurol. 2012;69:773-7.
    PubMed     Text format     Abstract available
    
    
    April 2012
30. QUEK AM , McKeon A, Lennon VA, Mandrekar JN, et al
    Effects of Age and Sex on Aquaporin-4 Autoimmunity.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
31. TORKILDSEN O , Wergeland S, Bakke S, Beiske AG, et al
    omega-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
32. GOLDENHOLZ DM , Wong VS, Bateman LM, Apperson M, et al
    Treatment of gamma-Aminobutyric AcidBReceptor-Antibody Autoimmune Encephalitis With Oral Corticosteroids.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
33. RENARD D , Poalelungi A, Collombier L, Labauge P, et al
    Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
    Arch Neurol. 2012;69:541-2.
    PubMed     Text format    
    
    
    
34. RICHMAN DP , Nishi K, Morell SW, Chang JM, et al
    Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes.
    Arch Neurol. 2012;69:453-60.
    PubMed     Text format     Abstract available
    
    
    March 2012
35. QUEK AM , Britton JW, McKeon A, So E, et al
    Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
36. BERGEY GK
    Autoantibodies in the Patient With Drug-Resistant Epilepsy: Are We Missing a Treatable Etiology?
    Arch Neurol. 2012.
    PubMed     Text format    
    
    
    
37. BOURRE B , Zephir H, Ongagna JC, Cordonnier C, et al
    Long-term follow-up of acute partial transverse myelitis.
    Arch Neurol. 2012;69:357-62.
    PubMed     Text format     Abstract available
    
    
    
38. MEALY MA , Newsome S, Greenberg BM, Wingerchuk D, et al
    Low serum vitamin D levels and recurrent inflammatory spinal cord disease.
    Arch Neurol. 2012;69:352-6.
    PubMed     Text format     Abstract available
    
    
    February 2012
39. SINNECKER T , Mittelstaedt P, Dorr J, Pfueller CF, et al
    Multiple Sclerosis Lesions and Irreversible Brain Tissue Damage: A Comparative Ultrahigh-Field Strength Magnetic Resonance Imaging Study.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
40. VILLAR LM , Garcia-Sanchez MI, Costa-Frossard L, Espino M, et al
    Immunological markers of optimal response to natalizumab in multiple sclerosis.
    Arch Neurol. 2012;69:191-7.
    PubMed     Text format     Abstract available
    
    
    
41. HAVLA JB , Pellkofer HL, Meinl I, Gerdes LA, et al
    Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
    Arch Neurol. 2012;69:262-4.
    PubMed     Text format     Abstract available
    
    
    
42. KLEITER I , Hellwig K, Berthele A, Kumpfel T, et al
    Failure of natalizumab to prevent relapses in neuromyelitis optica.
    Arch Neurol. 2012;69:239-45.
    PubMed     Text format     Abstract available
    
    
    
43. MCKEON A , Robinson MT, McEvoy KM, Matsumoto JY, et al
    Stiff-man syndrome and variants: clinical course, treatments, and outcomes.
    Arch Neurol. 2012;69:230-8.
    PubMed     Text format     Abstract available
    
    
    January 2012
44. MUPPIDI S , Scribner M, Gibbons CH, Adams-Huet B, et al
    A Unique Manifestation of Pupillary Fatigue in Autoimmune Autonomic Ganglionopathy.
    Arch Neurol. 2012.
    PubMed     Text format     Abstract available
    
    
    
45. POOL V , Gordon DM, Decker M
    Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow Fever vaccination.
    Arch Neurol. 2012;69:144.
    PubMed     Text format    
    
    
    
46. MARCUS JF , Shalev SM, Harris CA, Goodin DS, et al
    Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
    Arch Neurol. 2012;69:129-32.
    PubMed     Text format     Abstract available
    
    
    
47. CARAMANOS Z , Francis SJ, Narayanan S, Lapierre Y, et al
    Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.
    Arch Neurol. 2012;69:89-95.
    PubMed     Text format     Abstract available
    
    
    
48. CHERIYAN J , Kim S, Wolansky LJ, Cook SD, et al
    Impact of inflammation on brain volume in multiple sclerosis.
    Arch Neurol. 2012;69:82-8.
    PubMed     Text format     Abstract available
    
    
    
49. GORMAN MP , Tillema JM, Ciliax AM, Guttmann CR, et al
    Daclizumab use in patients with pediatric multiple sclerosis.
    Arch Neurol. 2012;69:78-81.
    PubMed     Text format     Abstract available
    
    
    
50. TEZER FI , Erdener E, Sel CG, Mehdikanova L, et al
    Daytime polysomnography recording in LIG1 --related limbic encephalitis.
    Arch Neurol. 2012;69:145-6.
    PubMed     Text format    
    
    
    
51. USMANI N , Bedi G, Lam BL, Sheremata WA, et al
    Association between paroxysmal tonic spasms and neuromyelitis optica.
    Arch Neurol. 2012;69:121-4.
    PubMed     Text format     Abstract available
    
    
    December 2011
52. GIBBONS CH , Centi J, Vernino S, Freeman R, et al
    Autoimmune Autonomic Ganglionopathy With Reversible Cognitive Impairment.
    Arch Neurol. 2011.
    PubMed     Text format     Abstract available
    
    
    
53. RICHMAN DP
    Antibodies to Low Density Lipoprotein Receptor-Related Protein 4 in Seronegative Myasthenia Gravis.
    Arch Neurol. 2011.
    PubMed     Text format    
    
    
    
54. ZHANG B , Tzartos JS, Belimezi M, Ragheb S, et al
    Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis.
    Arch Neurol. 2011.
    PubMed     Text format     Abstract available
    
    
    
55. ORTIZ GA , Lagari-Libhaber V, Prieto-Sanchez LM, Rabinstein AA, et al
    Propylthiouracil-induced lupus, antiphospholipid syndrome, and stroke in a patient with graves hyperthyroidism.
    Arch Neurol. 2011;68:1587-90.
    PubMed     Text format     Abstract available
    
    
    
56. FILIPPI M , Rocca MA, De Stefano N, Enzinger C, et al
    Magnetic resonance techniques in multiple sclerosis: the present and the future.
    Arch Neurol. 2011;68:1514-20.
    PubMed     Text format     Abstract available
    
    
    
57. WILLIAMS MA , Venkatesan A
    No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency: a call for the IDEAL model.
    Arch Neurol. 2011;68:1510-2.
    PubMed     Text format    
    
    
    November 2011
58. TUR C , Montalban X, Tintore M, Nos C, et al
    Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis: Five-Year Clinical Trial Follow-up.
    Arch Neurol. 2011;68:1421-7.
    PubMed     Text format     Abstract available
    
    
    
59. FINELLI PF , Uphoff DF
    Ring sign on diffusion-weighted imaging.
    Arch Neurol. 2011;68:1474-5.
    PubMed     Text format    
    
    
    
60. CHAN KH , Tse CT, Chung CP, Lee RL, et al
    Brain involvement in neuromyelitis optica spectrum disorders.
    Arch Neurol. 2011;68:1432-9.
    PubMed     Text format     Abstract available
    
    
    
61. SAURE C , Warnke C, Zohren F, Schroeder T, et al
    Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.
    Arch Neurol. 2011;68:1428-31.
    PubMed     Text format     Abstract available
    
    
    
62. KIM SH , Kim W, Li XF, Jung IJ, et al
    Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.
    Arch Neurol. 2011;68:1412-20.
    PubMed     Text format     Abstract available
    
    
    October 2011
63. KINKEL RP , Dontchev M, Kollman C, Skaramagas TT, et al
    Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes: A 10-Year Follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Ne
    Arch Neurol. 2011.
    PubMed     Text format     Abstract available
    
    
    
64. SHOAMANESH A , Chapman K, Traboulsee A
    Postvaccination Miller Fisher syndrome.
    Arch Neurol. 2011;68:1327-9.
    PubMed     Text format     Abstract available
    
    
    September 2011
65. QIAN P , Cross AH, Naismith RT
    Lack of response to monoclonal antibody therapy in neuromyelitis optica.
    Arch Neurol. 2011;68:1207-9.
    PubMed     Text format    
    
    
    
66. GHAVANINI AA , Munoz DG
    Primary cerebral angiitis associated with amyloid angiopathy.
    Arch Neurol. 2011;68:1202-3.
    PubMed     Text format    
    
    
    August 2011
67. KITLEY JL , Leite MI, Matthews LA, Palace J, et al
    Use of mitoxantrone in neuromyelitis optica.
    Arch Neurol. 2011;68:1086.
    PubMed     Text format    
    
    
    
68. AMBROSE CS , Loop B, Miday R
    A case report of transverse myelitis following influenza vaccination.
    Arch Neurol. 2011;68:1085.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: